Prihlásiť sa Zaregistrujte sa zadarmo

Prevádzková marža spoločnosti Neovacs S.A

Aká je hodnota metriky Prevádzková marža spoločnosti Neovacs S.A?

Hodnota metriky Prevádzková marža spoločnosti Neovacs S.A. je -12,000.00%

Aká je definícia metriky Prevádzková marža?



Prevádzková marža je pomer prevádzkových výnosov vydelený čistými predajmi a vyjadrený v percentách.

Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.

Prevádzková marža spoločností v sektore Health Care sektor na EURONEXT v porovnaní so spoločnosťou Neovacs S.A

Čomu sa venuje spoločnosť Neovacs S.A?

Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.

Firmy s metrikou prevádzková marža podobnou spoločnosti Neovacs S.A



  • Hodnota metriky Prevádzková marža spoločnosti BrainChip Ltd je -12,387.93%
  • Hodnota metriky Prevádzková marža spoločnosti Stavely Minerals je -12,305.56%
  • Hodnota metriky Prevádzková marža spoločnosti Key Petroleum je -12,250.00%
  • Hodnota metriky Prevádzková marža spoločnosti Aurora Labs je -12,061.49%
  • Hodnota metriky Prevádzková marža spoločnosti Constellation Resources je -12,049.12%
  • Hodnota metriky Prevádzková marža spoločnosti Ovid Therapeutics Inc je -12,008.28%
  • Hodnota metriky Prevádzková marža spoločnosti Neovacs S.A je -12,000.00%
  • Hodnota metriky Prevádzková marža spoločnosti Verb Technology je -11,788.24%
  • Hodnota metriky Prevádzková marža spoločnosti Albion Resources Ltd je -11,571.46%
  • Hodnota metriky Prevádzková marža spoločnosti Golden Mile Resources je -11,516.67%
  • Hodnota metriky Prevádzková marža spoločnosti Internet of Things je -11,511.14%
  • Hodnota metriky Prevádzková marža spoločnosti Predictiv AI je -11,511.14%
  • Hodnota metriky Prevádzková marža spoločnosti genedrive plc je -11,459.18%